Search Results 181-190 of 6021 for albumin

1. Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

   Serum calcium or albumin-adjusted serum calcium >= 2.0 mmol/L (8.0 mg/dL) and =< 2.9 mmol/L (11.5 mg/dL); All patients and/or their parents or legal ...

2. A Study of 177Lu-FAP-2286 in Advanced Solid Tumors (LuMIERE) - Mayo Clinic

   institutional ULN or if known Gilbert's syndrome then ≤ 3 × institutional ULN; iii. Serum albumin ≥ 30 g/L (3 g/dL) and iv. INR ≤ 1.5 x ULN and activated ...

3. A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   Serum albumin less than (<) 2.5 grams per deciliter (g/dL); Positive test for human immunodeficiency virus (HIV) and/or active hepatitis B or hepatitis C or ...

4. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   Patient must have adequate nutritional status with Body Mass Index (BMI) > 18 kg/m^2 and body weight of > 40 kg with serum albumin > 3 g/dL. Baseline ...

5. Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

   Serum albumin ≥ 3.5 g/dL;; Serum potassium ≥ 3.5 mmol/L;; Fasting glucose ≤ 150 mg/dL (8.3 mmol/L) and hemoglobin A1c ≤ 7.5% (58 mmol/mol). Ability to ...

6. A Study to Evaluate Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers - Mayo Clinic

   Serum albumin >= 2.8 g/dL (obtained within 28 days prior to registration). Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) (except ...

7. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

   ... albumin levels (+/-10%). Female participants: Contraceptive use by women should be consistent with local regulations regarding the methods of contraception ...

8. A Study to Evaluate Pembrolizumab with Standard Therapy to Treat Newly-diagnosed Glioblastoma - Mayo Clinic

   Albumin ≥ 2.5 mg/dL;; Total bilirubin ≤ 1.5 x ULN OR Direct bilirubin ≤ULN for patients with total bilirubin levels > 1.5 x ULN;; Aspartate transaminase ...

9. A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer - Mayo Clinic

   Serum albumin ≥ 3.0 g/dL. Exclusion Criteria: Prior systemic treatment with androgen deprivation therapy and/or first-generation anti-androgen (e.g. ...

10. Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Mayo Clinic

    - Albumin, S > 1.5 x ULN (within 30 days of randomization). - Protein, total, S > 1.5 x ULN (within 30 days of randomization). - Creatinine > 1.5 x ULN ...